Abstract
The present investigation was aimed at establishing whether interferon (IFN)-beta would induce the synthesis of autoantibodies in patients affected by multiple sclerosis (MS). The titres of different autoantibodies were measured in a group of 68 relapsing-remitting MS patients before and during treatment with human recombinant IFN-beta1a (3 MIU or 9 MIU subcutaneously 3x a week). ANA, anti-thyroid, anticardiolipin serum autoantibodies were assayed in all cases: when patients were found positive to ANA > 1 : 40, they were also tested for anti-DNA and anti-ENA antibodies. No increase was found in autoantibodies synthesis during 6 months of r-hIFNbeta1a therapy, either at low or high dosages. The percentage of patients positive to different types of autoantibodies varied between 0 and 29%, which are values similar to those already reported in untreated MS patients. Our data indicate that the short-term use of IFN-beta1a in MS is safe in terms of the induction of humoral autoimmune responses: however, further follow-up is needed to confirm these findings during long-term treatments.
References
Jan 1, 1992·Autoimmunity·G Valesini, Y Shoenfeld
May 15, 1990·Cancer·K C ConlonJ W Clark
Nov 1, 1983·Neurology·J F Kurtzke
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Aug 1, 1982·Archives of Neurology·P Dore-DuffyR B Zurier
Jan 1, 1995·Hormone Research·C CarellaG Lombardi
May 1, 1994·The Annals of Pharmacotherapy·J F Connelly
Sep 1, 1993·Acta Neurologica Scandinavica·T FukazawaK Tashiro
Mar 1, 1996·Annals of Neurology·L D JacobsR H Whitham
Feb 9, 1996·Cell·J N Ihle
Sep 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·C PozzilliC Fieschi
Citations
Jan 27, 2000·Current Opinion in Rheumatology·R A Watts
Feb 12, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Giovanni FrisulloClaudio Gasperini
May 23, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Tatiana KoudriavtsevaPaola Cordiali-Fei
Jun 29, 2000·Multiple Sclerosis : Clinical and Laboratory Research·O CiccarelliC Pozzilli
Apr 7, 2005·The Journal of Clinical Endocrinology and Metabolism·N CaraccioF Monzani
May 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·N GargM Ramanathan
Feb 15, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A Bayas, P Rieckmann
Aug 9, 2001·Acta Neurologica Scandinavica·C de AndrésF J López Longo
Jul 9, 2004·Current Opinion in Allergy and Clinical Immunology·Richard W Weber
Aug 12, 2009·Muscle & Nerve
Nov 15, 2011·Lupus·M Szmyrka-KaczmarekJ Szechinski
Oct 19, 2014·Lupus·I UthmanG R V Hughes
Sep 14, 2012·Neurological Research·Robert ZivadinovBianca Weinstock-Guttman
Jan 18, 2012·Multiple Sclerosis : Clinical and Laboratory Research·G GiovannoniE Waubant
May 16, 2009·Journal of Neuroimmunology·Joerg-Patrick Stübgen